| Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis : Insights From JAK, an International Registry Collaboration | Arthritis & rheumatology |  | | 2026 | 1 | 0 |
|
| Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs : data from an international collaboration of registries (the "JAK-pot" study) | Arthritis & rheumatology | | | 2025 | 95 | 161 |
|
| Loss of body weight is dose-dependently associated with reductions in symptoms of hip osteoarthritis | International journal of obesity | | | 2024 | 58 | 230 |
|
| Association of long-term use of non-steroidal anti-inflammatory drugs with knee osteoarthritis : a prospective multi-cohort study over 4-to-5 years | Scientific reports | | | 2024 | 46 | 257 |
|
| Bisphosphonates show no association with preventing, slowing, or delaying radiographic changes and pain in hip osteoarthritis : A 4‐year study in female adults using data from the Osteoarthritis Initiative Study | International journal of rheumatic diseases | | | 2024 | 59 | 125 |
|
| Evaluation of a measure of end-stage knee osteoarthritis compared to total knee replacement: An observational study using multicohort data | Seminars in arthritis and rheumatism | | | 2024 | 85 | 200 |
|
| Investigation of the association of long-term NSAID use with radiographic hip osteoarthritis over four to five years: Data from the OAI and CHECK studies | Osteoarthritis and cartilage open | | | 2024 | 72 | 120 |
|
| Predicting the onset of end-stage knee osteoarthritis over two- and five-years using machine learning | Seminars in arthritis and rheumatism | | | 2024 | 122 | 425 |
|
